Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods - Test2 - elhamkhani - TriplyDB

Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods

Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods

http://www.wikidata.org/entity/Q26853516

about

New perspectives in glioblastoma antiangiogenic therapy Advanced magnetic resonance imaging methods for planning and monitoring radiation therapy in patients with high-grade glioma Association of the CCDC26 rs4295627 polymorphism with the risk of glioma: Evidence from 7,290 cases and 11,630 controls Advanced neuroimaging in the clinic: critical appraisal of the evidence base.Oligodendrogliomas in pediatric and adult patients: an outcome-based study from the Surveillance, Epidemiology, and End Result database Grading of Gliomas by Using Radiomic Features on Multiple Magnetic Resonance Imaging (MRI) Sequences.Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approaches.Nanoparticle-loaded macrophage-mediated photothermal therapy: potential for glioma treatment Reduction in gap junction intercellular communication promotes glioma migration.Expression of p16 and Survivin in gliomas and their correlation with cell proliferation The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping.Paeoniflorin inhibits human glioma cells via STAT3 degradation by the ubiquitin-proteasome pathway.Low MiR-149 expression is associated with unfavorable prognosis and enhanced Akt/mTOR signaling in glioma.18F-fluorothymidine PET imaging in gliomas: an update.miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.Specific protein 1 depletion attenuates glucose uptake and proliferation of human glioma cells by regulating GLUT3 expression.Ubiquitin-specific protease 28 is overexpressed in human glioblastomas and contributes to glioma tumorigenicity by regulating MYC expression.ImmunoPET Imaging of CD146 Expression in Malignant Brain Tumors The mechanisms of malic enzyme 2 in the tumorigenesis of human gliomas.The Impact of MMP-2 and Its Specific Inhibitor TIMP-2 Expression on the WHO Grade and Prognosis of Gliomas in Chinese Population: a Meta-Analysis.Segmentation of peritumoral oedema offers a valuable radiological feature of cerebral metastasis.Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.Raf kinase inhibitor protein (RKIP) inhibits the cell migration and invasion in human glioma cell lines in vitro.MicroRNA-210 and Endoplasmic Reticulum Chaperones in the Regulation of Chemoresistance in Glioblastoma.Insights into molecular therapy of glioma: current challenges and next generation blueprint Cyclooxygenase inhibitor induces the upregulation of connexin-43 expression in C6 glioma cells.Advanced MRI increases the diagnostic accuracy of recurrent glioblastoma: Single institution thresholds and validation of MR spectroscopy and diffusion weighted MR imaging.Correlation of survivin and B-cell lymphoma 2 expression with pathological malignancy and anti-apoptotic properties of glial cell tumors.Intracranial Glioblastomas: New Hope for an Effective Treatment.Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.Paeoniflorin exerts antitumor effects by inactivating S phase kinase-associated protein 2 in glioma cells.PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator.MRI combined with PET-CT of different tracers to improve the accuracy of glioma diagnosis: a systematic review and meta-analysis.Fluorescence-Guided versus Conventional Surgical Resection of High Grade Glioma: A Single-Centre, 7-Year, Comparative Effectiveness Study.Suppression of the Smurf1 Expression Inhibits Tumor Progression in Gliomas.Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.Targeting the T-Lak cell originated protein kinase by OTS964 shrinks the size of power-law coded heterogeneous glioma stem cell populations.Malignant Astrocytic Tumor Progression Potentiated by JAK-mediated Recruitment of Myeloid Cells.Highly Sensitive MoS-Indocyanine Green Hybrid for Photoacoustic Imaging of Orthotopic Brain Glioma at Deep Site Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1]

P2860

Q26746028-4A5694D3-8E53-4394-8AD7-3D3B451AC99D Q26826862-CED3A436-5018-4A0A-9B37-4767BF729E79 Q28392762-7F37220D-A799-4FBE-BFED-FD2966BBA6B3 Q31076319-7BC1CE84-3C69-42E4-B821-CD8D94E59611 Q33649896-D562D2C6-8FCC-405B-9E65-3B1465144596 Q33702758-1A165405-8481-4CD2-BEE7-34D8CA59AAE3 Q34305848-EE9E8396-3BB9-4497-B0D0-C23CA875A4A2 Q35582867-0BFD3F31-F87E-447E-8FBB-E34F7C69240E Q35793827-DE8A582C-AF04-4558-BCDB-90F252A72A28 Q35803811-0429F2F1-74CD-4080-9803-44EB586244AB Q36095642-0D9D723A-984C-4649-8FC6-2AD60C4B7630 Q36176779-5C570B5A-F01C-4D8B-98D9-6FF0DD2C1675 Q36261690-CD4D59EF-F095-4402-B34B-60A353117060 Q36404866-7ED956FC-6737-4922-9436-4921CD5F68FE Q36557234-6698A5C7-A0BD-4C56-B765-512A8E2AEE0C Q37001138-3E57C51F-1E30-4B9F-A512-3E1FA3EA12C8 Q37071678-76277686-9740-4C51-A88B-B4004DD232D2 Q37072090-175B6A6F-DA77-4702-9A15-1C35FDC1B21D Q37520257-0D3B436B-559B-41ED-B513-0E656116AB92 Q37569910-89288B8F-CCCA-4707-9A9A-D7F15D690236 Q37600899-ECDA0025-1903-41A1-93A0-33641358EB0A Q37603380-4917577B-4ED4-4863-88B5-79470D424C4A Q38798451-E525FF46-B727-4B87-ADC2-627E0B11DC44 Q39041827-76D3AD0C-EC62-49B9-8E0A-E25D97C0E5AF Q39187306-FB3E25D2-FF50-4810-A45A-B8CFFCEFE6BC Q39653261-5D0E0B25-691F-4224-B1C4-266472678CBB Q41776963-82EF8648-82C3-4C8E-9441-DB815007BA17 Q41869508-4CD0F1DB-9F05-45FF-A700-5761F7CCF107 Q43236314-99FB1346-B152-4BB1-BBDC-A71B91CC26FE Q47161135-01BFB3B3-33B6-4592-A9B1-F0895CDC7228 Q47246307-9C63596F-73B8-4C5E-8BF0-6F8A92B908D9 Q47842746-E1C583A4-9262-42B1-93AE-C931E4B81F04 Q47973107-FFDB60DC-A047-42BC-8FB7-BC2500BBB8E7 Q48117952-99195EE9-97EC-487A-BB6F-8239E9F7737E Q48254991-269F0AE5-3FD7-4BE9-AF57-670FC85FF46F Q48269310-7CD20186-5A0B-433B-842B-15BD88A818CA Q49425250-8FC9E09C-3BE4-4232-90AD-ECBE607ABEB2 Q49510141-5E11A3F7-525D-4976-9402-4AAEE452A85F Q58582432-B7B2467F-3AB6-428B-A66C-9D2B100673CB Q58705906-436A2A6B-34DF-49CB-8CC8-9D844C22AEB9

P2860

Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods

http://www.wikidata.org/entity/Q26853516

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Malignant gliomas: current per ...... d quantitative imaging methods

@ast

Malignant gliomas: current per ...... d quantitative imaging methods

@en

Malignant gliomas: current per ...... d quantitative imaging methods

@nl

type

label

Malignant gliomas: current per ...... d quantitative imaging methods

@ast

Malignant gliomas: current per ...... d quantitative imaging methods

@en

Malignant gliomas: current per ...... d quantitative imaging methods

@nl

prefLabel

Malignant gliomas: current per ...... d quantitative imaging methods

@ast

Malignant gliomas: current per ...... d quantitative imaging methods

@en

Malignant gliomas: current per ...... d quantitative imaging methods

@nl

P1433

Q26853516-B7B8BA4A-36ED-4D03-870A-891B8609FE51

P1476

Q26853516-ECB77066-02C8-4E7D-AAA7-75788C3E3414

P2093

Q26853516-3F423A8D-41D2-41C6-9CE0-12F6ECE5BFCD

Q26853516-56C7B06A-ADD2-47FA-BFB8-A00A42C59181

Q26853516-66837452-EB5B-42DE-87DE-70F1239C2A78

Q26853516-CC4051A8-0B72-4F43-8C25-3F0300FA1BCF

Q26853516-D9DB331F-285C-45EE-ABF8-7FE5AA4FCA80

P2860

Q26853516-00B1A038-2FC3-411C-BF02-525A35A7E6F7

Q26853516-020A462B-A194-43CB-A620-873ABB030AC5

Q26853516-0249E416-00B8-4CC1-A723-DFD0D612FB47

Q26853516-0354758A-40C9-478A-93C8-7EE837CFF41E

Q26853516-03AC9337-CA2E-4E8C-9322-18D967B2E8F2

Q26853516-044A32EB-8F6F-4819-9340-282ABEC286F7

Q26853516-0484370D-CD59-4145-8E03-1555742D92AD

Q26853516-065DC17A-FCE1-4F32-AB5E-32C2AAA374A7

Q26853516-07AC7070-DC32-4308-9347-744C6ACF0DBA

Q26853516-07D90DDA-E3B5-4DDC-9D85-6DA462CF7133

P304

Q26853516-291497FA-9953-4281-8E48-A4C0F664FFF8

P31

Q26853516-8ECADDB8-40EB-4332-AAAA-4B1CDBFCB754

P3181

Q26853516-8934C8DA-B296-4A36-BD1C-F5B4053A5941

P356

Q26853516-5654AF36-3C99-4FC2-A18A-97449043757F

P407

Q26853516-22984421-D479-4F45-946A-24DCE69D3C95

P478

Q26853516-1F53711F-AA64-433F-A927-C7B15DA7EE06

P577

Q26853516-6C0487F1-48D7-47BA-94A0-158845549F80

P698

Q26853516-9EC64953-96BC-4A3F-9696-6947429EE21C

P932

Q26853516-FD95AB0D-02D4-4162-8AA5-A27213B7A39A

P3181

P356

P1433

Cancer Management and Research

P1476

Malignant gliomas: current per ...... d quantitative imaging methods

@en

P2093

Frank S Lieberman

http://www.w3.org/2001/XMLSchema#string

James M Mountz

http://www.w3.org/2001/XMLSchema#string

Matthew J Oborski

http://www.w3.org/2001/XMLSchema#string

Misun Hwang

http://www.w3.org/2001/XMLSchema#string

Rafay Ahmed

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The 2007 WHO classification of tumours of the central nervous system

Wnt/β-catenin signaling and disease

Will kinase inhibitors make it as glioblastoma drugs?

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

MGMT gene silencing and benefit from temozolomide in glioblastoma.

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

P304

149-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1572518

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/CMAR.S54726

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24711712

http://www.w3.org/2001/XMLSchema#string

P932

3969256

http://www.w3.org/2001/XMLSchema#string